For Residents

Basal Cell Carcinoma: Hedgehog Pathway Inhibitors and Beyond

Cutis. 2013 June;91(6):E1-E4
By
Brooke Walls, DO

An evolving theme in cutaneous oncology is targeted therapy. Blockade of the hedgehog signaling pathway has been a breakthrough in the management of patients with advanced basal cell carcinoma (BCC). Although promising results have been reported, recurrence and evolution of new tumors via circumvention of traditional pathways has occurred. Dr. Brooke Walls reviews the hedgehog signaling pathway, tumorigenesis, and novel strategies for the development of next-generation drugs.
Read the Full Article

 

Recommended Reading

Sequential laser therapy clears basal cell carcinomas
MDedge Dermatology
Health Care Reform Produces Both Heat and Light With the Indoor Tanning Tax
MDedge Dermatology
Pigmented Bowen Disease in a Black Patient: Novel Dermoscopic Findings [letter]
MDedge Dermatology
Super Giant Squamous Cell Carcinomas
MDedge Dermatology
Cutaneous Vulvar Metastases in a Patient With Anal Squamous Cell Carcinoma
MDedge Dermatology
What Is Your Diagnosis? Extraocular Sebaceous Carcinoma
MDedge Dermatology
Incidental (Malignancy) and Coincidental (Idiopathic Polydactylous Longitudinal Erythronychia) Conditions in Patients With Segmental Neurofibromatosis
MDedge Dermatology
Pancreatic Panniculitis Secondary to Acinar Cell Carcinoma of the Pancreas
MDedge Dermatology
Squamous Cell Carcinoma of the Lip Associated With Adalimumab Therapy for Ankylosing Spondylitis: A Case Report and Review of TNF-α Inhibitors and Cutaneous Carcinoma Risk
MDedge Dermatology
Sweet Syndrome Preceding a Carcinoid Lung Tumor and Multiple Myeloma
MDedge Dermatology